140 results
Page 4 of 7
8-K
EX-99.1
ca1ivhav
31 Jan 22
Gamida Cell Provides Key Program Updates and 2022 Financial Guidance
9:00am
8-K
EX-99.1
t7evfo8jc
19 Jan 22
Gamida Cell Provides Update on Omidubicel BLA Submission
7:00am
6-K
EX-99.1
0isw6 lqcr1lm1u
15 Nov 21
Gamida Cell Reports Third Quarter 2021 Financial Results
7:29am
6-K
EX-99.1
j78y5s0
12 Nov 21
Gamida Cell Provides Update on Pre-BLA Meeting with FDA for Omidubicel
7:17am
6-K
EX-99.1
50680xl hl
26 Oct 21
Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day
7:30am
6-K
EX-99.1
wn12 d5tb
12 Oct 21
Report of Foreign Private Issuer
4:32pm
F-3
EX-1.2
krawc 3lb
13 Sep 21
Shelf registration (foreign)
12:00am
F-3
z7v1n
13 Sep 21
Shelf registration (foreign)
12:00am
F-3
EX-4.3
x7ac2cusvgt
13 Sep 21
Shelf registration (foreign)
12:00am
6-K
EX-99.1
dw9 yk2zk1yzvpw
13 Aug 21
Report of Foreign Private Issuer
4:04pm
6-K
EX-99.1
kkf63k
7 Jun 21
Gamida Cell Announces Appointment of Senior Vice President, Global Operations and Manufacturing and Provides Commercial Manufacturing Update
7:11am
6-K
EX-99.1
jes6ry0 mi53t9n
11 May 21
Gamida Cell Reports First Quarter 2021 Financial Results and Provides Company Update
8:28am
6-K
EX-99.1
ovrigb9jt3pd8oh
9 Mar 21
Gamida Cell Reports Full Year 2020 Financial Results and Provides Company Update
4:08pm
F-3
dt3fa uzukaaffbi0a
1 Mar 21
Shelf registration (foreign)
4:37pm
6-K
EX-10.1
t2wq7mh10b0sjfb3
16 Feb 21
Gamida Cell Announces $75 Million Financing with Highbridge Capital Management
8:57am
6-K
EX-99.1
g4p9aebq0f
16 Feb 21
Gamida Cell Announces $75 Million Financing with Highbridge Capital Management
8:57am
6-K
EX-4.1
xyfrdvifvv9x
16 Feb 21
Gamida Cell Announces $75 Million Financing with Highbridge Capital Management
8:57am
6-K
EX-99.1
cezko
10 Feb 21
Current report (foreign)
4:01pm
6-K
EX-99.1
fhgbjt
21 Dec 20
Gamida Cell Announces Pricing of $65 Million Public Offering of Ordinary Shares
4:38pm